Diagnosis and Treatment Strategies for Hereditary Pancreatic Cancer Syndrome

A germline pathogenic variant of BRCA suggests the effectiveness of platinum agents and PARP inhibitors against pancreatic cancers. The need for genetic counseling and testing is increasing to support at-risk individuals in making autonomous decisions based on sufficient information.